Detalhe da pesquisa
1.
PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine.
Nat Immunol
; 23(8): 1183-1192, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35902637
2.
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response.
Nature
; 560(7718): 382-386, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30089911
3.
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response.
Nature
; 545(7652): 60-65, 2017 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28397821
4.
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(4): 387-405, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35390769
5.
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020.
J Natl Compr Canc Netw
; 18(3): 230-241, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32135517
6.
Lupus-like cutaneous reaction following pembrolizumab: An immune-related adverse event associated with anti-PD-1 therapy.
J Cutan Pathol
; 45(1): 74-77, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29028121
7.
FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma.
Clin Cancer Res
; 30(9): 1758-1767, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38263597
8.
Advanced Practice Provider Model for Urgent Oncology Care.
J Adv Pract Oncol
; 14(1): 73-81, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36741208
9.
Diverse cutaneous side effects associated with BRAF inhibitor therapy: a clinicopathologic study.
J Am Acad Dermatol
; 67(6): 1265-72, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22609219
10.
Side effects in melanoma patients receiving adjuvant interferon alfa-2b therapy: a nurse's perspective.
Support Care Cancer
; 20(8): 1601-11, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22562583
11.
IL-8 and cathepsin B as melanoma serum biomarkers.
Int J Mol Sci
; 12(3): 1505-18, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21673904
12.
Automated Text-Based Symptom Monitoring With Rapid Clinician Triage for Patients With Cancer and Suspected or Confirmed COVID-19.
JCO Clin Cancer Inform
; 5: 1134-1140, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34767436
13.
Ipilimumab-associated Sweet syndrome in a melanoma patient.
J Am Acad Dermatol
; 71(5): e211-3, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25437997
14.
A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma.
Nat Med
; 25(3): 454-461, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30804515
15.
Timing of Onset of Adverse Cutaneous Reactions Associated With Programmed Cell Death Protein 1 Inhibitor Therapy.
JAMA Dermatol
; 154(9): 1057-1061, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30027278
16.
PD-1 Inhibitor Therapy: Consensus Statement From the Faculty of the Melanoma Nursing Initiative on Managing Adverse Eventsâ©.
Clin J Oncol Nurs
; 21(4 Suppl): 42-51, 2017 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28738055
17.
Improving the Safety of Oral Chemotherapy at an Academic Medical Center.
J Oncol Pract
; 12(1): e71-6, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26733627
18.
Acute visual loss after ipilimumab treatment for metastatic melanoma.
J Immunother Cancer
; 4: 66, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27777775
19.
What you are missing could matter: a rare, complex BRAF mutation affecting codons 599, 600, and 601 uncovered by next generation sequencing.
Cancer Genet
; 207(6): 272-5, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25178945
20.
Health-Care Metrics in Oncology.
J Adv Pract Oncol
; 6(1): 57-61, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26413375